$Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma$

Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma

Patients with Burkitt lymphoma who are refractory to initial therapy or who relapse after undergoing intensive chemotherapy and autologous stem cell transplantation (ASCT) usually have a poor prognosis. While there has been considerable progress in the use of chimeric antigen receptor-modified (CAR)...

Full description

Bibliographic Details
Main Authors:	Jiaying Wu, Yang Cao, Qi Zhang, Wanying Liu, Xiaoxi Zhou, Xi Ming, Fankai Meng, Yicheng Zhang, Chunrui Li, Liang Huang, Jia Wei, Miao Zheng, Shangkun Zhang, Tongcun Zhang, Xiaojian Zhu, Na Wang, Jue Wang, Gaoxiang Wang, Jianfeng Zhou, Bo Liu, Yi Xiao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Immunology
Subjects:	Burkitt lymphoma chimeric antigen receptor immunotherapy transplantation cytokine release syndrome immune effector cell-associated neurotoxicity syndrome
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.879983/full

Similar Items

Bone Marrow Aplasia after CAR-T-Cell Therapy for Relapsed/Refractory Burkitt’s Lymphoma
by: Troy J. Kenkel, et al.
Published: (2023-10-01)

Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies
by: Chieh Yang, et al.
Published: (2023-10-01)

Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy
by: Robert C. Sterner, et al.
Published: (2022-08-01)

Invasive Fungal Disease After Chimeric Antigen Receptor-T Immunotherapy in Adult and Pediatric Patients
by: Paschalis Evangelidis, et al.
Published: (2025-02-01)

Burkitt lymphoma as fourth neoplasia in a patient affected by Cowden Syndrome with a novel PTEN germline pathogenic variant
by: Eugenio Galli, et al.
Published: (2020-06-01)

Features and outcomes of patients admitted to the ICU for chimeric antigen receptor T cell-related toxicity: a French multicentre cohort
by: Corentin Le Cacheux, et al.
Published: (2024-01-01)

Spontaneous tumor lysis syndrome (STLS) during biopsy for burkitt lymphoma: a case report
by: Sirui Pan, et al.
Published: (2024-03-01)

Yellow droopy eyes: A case of obstructive jaundice from Burkitt's lymphoma with involvement of bilateral cavernous sinus
by: Victor Ken On Chang, GDipDent, MD, MSurg, et al.
Published: (2023-03-01)

Reversible Posterior Leukoencephalopathy Syndrome Sometimes Could be Irreversible: A Case Following Tumor Lysis Syndrome in Childhood Burkitt′s Lymphoma
by: Rui Zhang, et al.
Published: (2016-01-01)

Novel pathophysiological insights into CAR-T cell associated neurotoxicity
by: Vassilis Genoud, et al.
Published: (2023-03-01)

CD19 chimeric antigen receptor T-cell therapy following autologous stem cell transplantation against relapsed or refractory Burkitt lymphoma/leukemia: A case report and literature review
by: Mingyu Ye, et al.
Published: (2022-10-01)

Risk factors and outcome of Chimeric Antigen Receptor T-Cell patients admitted to Pediatric Intensive Care Unit: CART-PICU study
by: Marina Caballero-Bellón, et al.
Published: (2023-08-01)

The influence of CRS and ICANS on the efficacy of anti-CD19 CAR-T treatment for B-cell acute lymphoblastic leukemia
by: Yuhan Ma, et al.
Published: (2024-09-01)

Linfoma de Burkitt Burkitt lymphoma
by: Fernando Sierra Arego, et al.
Published: (2012-03-01)

Linfoma Burkitt del seno esfenoidal en pediatría: Reporte de caso Burkitt Lymphoma of the Sphenoid Sinus in Children: Case Report
by: Jorge Docampo, et al.
Published: (2011-06-01)

Burkitt lymphoma presenting as cecum mass and spontaneous tumor lysis syndrome with hypercalcemia
by: Mahan Shafie, et al.
Published: (2023-02-01)

Linfoma de Burkitt esporádico en cavidad bucal. Caso clínico// Sporadic Burkitt´s lymphoma in the oral cavity. A clinical case report
by: María Belén Pagola
Published: (2021-01-01)

Immune effector cell‐associated haemophagocytic lymphohistiocytosis‐like syndrome
by: Enrico Schalk
Published: (2024-08-01)

Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma
by: Jiaying Wu, et al.
Published: (2024-11-01)

CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
by: Livio Pagano, et al.
Published: (2009-11-01)

Sporadic Burkitt lymphoma presenting with peritoneal lymphomatosis
by: Meriam Sabbah, et al.
Published: (2022-12-01)

Burkitt‐like lymphoma with 11q aberration
by: Katrina Collins, et al.
Published: (2019-09-01)

Case report: Sandwich therapy of CAR-T combined with ASCT: Sequential CAR-T cell therapy with ASCT after remission with CAR-T therapy caused long-term survival in a patient with relapsed/refractory Burkitt’s lymphoma with TP53 mutations
by: Qi Zhang, et al.
Published: (2023-03-01)

Hepatic mass: A rare presentation of childhood hepatic Burkitt lymphoma
by: Sneha Tandon, et al.
Published: (2020-06-01)

Distal colo-colonic intussusception caused by Burkitt's lymphoma
by: Kara Kennedy, et al.
Published: (2022-11-01)

Burkitt's Lymphoma Mimicking a Primary Gynecologic Tumor
by: Szu-Ching Lu, et al.
Published: (2006-06-01)

Efficacy and safety of CD19-specific CAR-T cell-based therapy in secondary central nervous system lymphoma
by: Huanxin Zhang, et al.
Published: (2022-08-01)

Incidence of immune effector cell-associated neurotoxicity among patients treated with CAR T-cell therapy for hematologic malignancies: systematic review and meta-analysis
by: Min Woo Han, et al.
Published: (2024-10-01)

A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma
by: Yifei Liu, et al.
Published: (2019-09-01)

A rare cause of vomiting in an adolescent: gastric Burkitt`s lymphoma
by: Derya Altay, et al.
Published: (2019-06-01)

Burkitt's lymphoma presenting as ovarian mass and ileocecal intussusception in an adult
by: Chung-Hsiung Liu, et al.
Published: (2018-01-01)

Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
by: Elizabeth L. Siegler, et al.
Published: (2020-08-01)

Gigantomastia During Pregnancy Due to Burkitt Lymphoma
by: Virginia Foreste, et al.
Published: (2021-01-01)

Uma Apreciação do Tumor de Burkitt
by: Joseph Burchenal
Published: (2023-08-01)

The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice
by: Ümit Yavuz Malkan, et al.
Published: (2016-11-01)

The effect of mutation on neurotoxicity reduction of new chimeric reteplase, a computational study
by: Pardis Mohammadi pour, et al.
Published: (2023-01-01)

Recaída de linfoma de Burkitt en paladar
by: Jessica Medina, et al.
Published: (2021-05-01)

A Case of Burkitt's Lymphoma Mimicking Peritonitis Carcinomatosa
by: Deram Büyüktaş, et al.
Published: (2020-08-01)

Burkitt Leukemia in a Child with Beta Thalassemia Major
by: Ghasem Miri-Aliabad, et al.
Published: (2022-01-01)

Management of chimeric antigen receptor T-cell-related toxicity of a patient affected by cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, followed by an intestinal perforation: a case report
by: G. Menardi, et al.
Published: (2025-01-01)